Current Assets: The sum of all assets that are classified as current, because they will provide a benefit within one year.
Medicenna Therapeutics Corp. (MDNAF) had Current Assets of $9.26B for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-3.13M |
|
-- |
|
-- |
|
$4.03M |
|
$-4.03M |
|
$0.90M |
|
$-3.13M |
|
$-3.13M |
|
$-3.13M |
|
$-3.13M |
|
$-3.13M |
|
$-3.13M |
|
$-4.03M |
|
$-4.02M |
|
83.42M |
|
83.42M |
|
$-0.04 |
|
$-0.04 |
|
| Balance Sheet Financials | |
|
Current Assets |
$9.26B |
$1.43M |
|
$108.31M |
|
$9.37B |
|
$3.46B |
|
-- |
|
$1.46B |
|
$4.92B |
|
$4.46B |
|
$4.42B |
|
$4.46B |
|
83.42M |
|
| Cash Flow Statement Financials | |
$-9.65M |
|
$0.00M |
|
$0.00M |
|
$17.82M |
|
$7.61M |
|
$-10.20M |
|
$0.85M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.68 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-9.64M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-0.07% |
|
-0.07% |
|
-0.03% |
|
-0.07% |
|
$53.41 |
|
$-0.12 |
|
$-0.12 |
|